Neutrophil gelatinase-associated lipocalin in dogs with naturally occurring renal diseases

Journal of Veterinary Internal Medicine

Volumn 28, Issue 2, 2014, Pages 437-442

  Hsu, W L ^a   Lin, Y S ^a   Hu, Y Y ^a   Wong, M L ^a   Lin, F Y ^a   Lee, Y J ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Azotemia; Outcome; Renal biomarkers; Renal failure; Survival

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LIPOCALIN; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN PROTEIN, DOG; ONCOPROTEIN;

ACUTE KIDNEY INJURY; ANIMAL; BLOOD; CASE CONTROL STUDY; DOG; DOG DISEASES; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; KIDNEY DISEASES; MALE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; VETERINARY;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; KIDNEY DISEASES; LIPOCALINS; MALE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84897632146     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12288     Document Type: Article

References (30)

1. Rivers BJ, Walter PA, O'Brien TD, et al. Evaluation of urine gamma-glutamyl transpeptidase-to-creatinine ratio as a diagnostic tool in an experimental model of aminoglycoside-induced acute renal failure in the dog. J Am Anim Hosp Assoc 1996;32:323-336.
2. Finco DR, Brown SA, Vaden SL, et al. Relationship between plasma creatinine concentration and glomerular filtration rate in dogs. J Vet Pharmacol Ther 1995;18:418-421.
3. Devarajan P. Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 2010;15:419-428.
4. Xu SY, Carlson M, Engstrom A, et al. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest 1994;54:365-376.
5. Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:10425-10432.
6. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997;45:17-23.
7. Schmidt-Ott KM, Mori K, Li JY, et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007;18:407-413.
8. Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004;15:3073-3082.
9. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231-1238.
10. Wagener G, Jan M, Kim M, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006;105:485-491.
11. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006;21:856-863.
12. Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007;22:2089-2095.
13. Constantin JM, Futier E, Perbet S, et al. Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: A prospective study. J Crit Care 2010;25:176 e171-176.
14. Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res 2009;32:77-80.
15. Shapiro NI, Trzeciak S, Hollander JE, et al. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 2010;56:52-59, e51.
16. Dent CL, Ma Q, Dastrala S, et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: A prospective uncontrolled cohort study. Crit Care 2007;11:R127.
17. Argyri I, Xanthos T, Varsami M, et al. The role of novel biomarkers in early diagnosis and prognosis of acute kidney injury in newborns. Am J Perinatol 2013;30:347-352.
18. Akcay AB, Ozlu MF, Sen N, et al. Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction. J Investig Med 2012;60:508-513.
19. Kumpers P, Hafer C, Lukasz A, et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010;14:R9.
20. Haase-Fielitz A, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant 2009;24:3349-3354.
21. Brunner HI, Mueller M, Rutherford C, et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2006;54:2577-2584.
22. Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007;22:101-108.
23. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Ren Fail 2008;30:625-628.
24. Chaudhary K, Phadke G, Nistala R, et al. The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease. Curr Diab Rep 2010;10:37-42.
25. Nickolas TL, Forster CS, Sise ME, et al. NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney Int 2012;82:718-722.
26. Lee YJ, Hu YY, Lin YS, et al. Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury. BMC Vet Res 2012;8:248.
27. Nabity MB, Lees GE, Cianciolo R, et al. Urinary biomarkers of renal disease in dogs with X-linked hereditary nephropathy. J Vet Intern Med 2012;26:282-293.
28. Segev G, Palm C, Leroy B, et al. Evaluation of neutrophil gelatinase-associated lipocalin as a marker of kidney injury in dogs. J Vet Intern Med 2013;27:1362-1367.
29. Lalanne A, Beaudeux JL, Bernard MA. NGAL: A biomarker of acute and chronic renal dysfunction. Ann Biol Clin (Paris) 2011;69:629-636.
30. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007;71:967-970.